AstraZeneca’s Trastuzumab deruxtecan therapy receives CDSCO nod to manage HER2- low & ultra-low…
The medicine is now indicated as a monotherapy for the treatment of adult patients with unresectable or metastatic breast cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
breast cancer
Eli Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program
TX-478 could potentially address 30-40 per cent of people with hormone-positive breast cancer, building on Lilly's advancements…
Shashvi Remedies develops breakthrough breast cancer formulation with promising results
Mumbai-based pharma company unveils a decade-long innovation showing over 80 per cent effectiveness in targeting cancer cells with…
Jiangsu Hansoh ADC HS-20093 holds potential to set new standard in SCLC second-line treatment in…
HS-20093: A breakthrough ADC poised to redefine second-line SCLC care in China, strengthening Jiangsu Hansoh's oncology leadership…
Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India:…
GlobalData reports the rise in HER2+ breast cancer cases, stressing the importance of cost-effective biosimilars as Zydus and…
AstraZeneca’s breast cancer drug combination fails in late-stage trial
The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients
Puma Biotechnology announces presentation of findings from a phase II study of alisertib in…
Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib
Puma Biotechnology, announced the…
Zum Heilen announces patent for cardamom-based nutraceutical Recovereez
Launches Recovereez at the World Spice Congress
Scientists investigate if prostate drug could also treat breast cancer that’s spread to the bone
When breast cancer cells spread to other parts of the body it is called secondary or metastatic breast cancer and although…
Glenmark reduces cost of Trastuzumab treatment in India
A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country